TimberTech Composite Decking Lawsuit: False Advertising Claims Investigated by Seeger Weiss
Seeger Weiss, LLP is investigating claims for a class action suit involving TimberTech composite decking.
Seeger Weiss, LLP is investigating claims for a class action suit involving TimberTech composite decking. TimberTech deck is supposed to be “low-maintenance,” and it is supposed to “maintain its color and beauty for years.” In fact, the company’s motto is, “Less Work, More Life.” Yet purchasers of the company’s decking material are complaining about staining, fading, blotching and discoloring within only a short period of time after installation.
Moreover, TimberTech’s customer support has been sub-par. The company often recommends to its frustrated customers a cleaner to be applied to the deck. After customers apply this cleaner, the results are minimal, at best. This certainly contradicts TimberTech’s claims that its decking product is “low-maintenance.”
In order to facilitate our lawsuit against TimberTech, we kindly ask that all purchasers of the company’s composite decking material come forward to discuss your claim. All initial attorney consultations are free of charge.
Seeger Weiss is a leader in consumer class action lawsuits. With experienced attorneys and locations throughout the United States, our firm strives to provide the highest quality of service to our clients. We treat each case with careful attention to ensure that consumers get the justice they deserve. Seeger Weiss, LLP has office locations in New York, New Jersey, Pennsylvania and California.
Valeant Pharmaceuticals International is a fast-growing company that is creating life and death scenarios for patients that rely on its drugs. This summer, nearly overnight, Valeant quadrupled its [...]October 5, 2015 By: Alexis Nielson read more
Attention: Chris Seeger, Partner, of Seeger Weiss LLP is currently investigating Volkswagen claims related to the recent recall. Seeger Weiss LLP is a leader in consumer class action lawsuits and has extensive [...]September 29, 2015 By: admin read more
For over 60 years Daraprim has been the standard drug for treating infections associated with AIDS. However, overnight that price has skyrocketed from an affordable $13.50 to an exorbitant $750. [...]September 22, 2015 By: Alexis Nielson read more